Digital Therapeutics: A New Age Medicine
Description
Digital Therapeutics: A New Age Medicine
Report Scope:
The current report covers the booming technology of digital therapeutics. It also investigates the current shift in trends away from conventional methods of treatment toward the advanced means offered by digital therapeutics. This report is an update of an earlier report of the same title but focuses on more in-depth information. This report offers a comprehensive analysis of the global digital therapeutics market. Segmentation is based on application and sales channels. Based on application, the market is segmented as diabetes, psychiatric and addiction, neurological, cardiovascular diseases, and others. Based on sales channel the market is segmented as business-to-consumer (B2C) and business-to-business (B2B). The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). For market estimates, data has been provided for 2019, 2020, and 2021 as the base year, 2022, and a forecast for 2027.
The report provides a detailed overview and analysis of the present and future global market for digital therapeutics. Industry growth drivers, restraints, and opportunities are also discussed in detail. The report also provides a competitive landscape, elaborative company profiles, and the impact of COVID-19 on the market. The report focuses on the companies that are developing and encouraging digital therapeutics technology and doing research to develop the technology further.
Report Includes:
A brief general outlook of the global market for digital therapeutics scenario
Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Highlights of the current and upcoming market potential for digital therapeutics, and areas of focus to forecast this market into various segments and subsegments
Updated information on market opportunities and drivers, key shifts and trends, regulations and industry specific challenges, and other factors that will shape this market demand in the coming years (2022-2027)
Identification of the companies best positioned to meet the demand owing to their proprietary technologies, product launches, mergers and acquisitions, and other market strategic advantages
Review of the technology landscape for digital therapeutics marketplace with emphasis on recently approved products as well as products under development or in different stages of clinical trials
Profile descriptions of the market leading participants, including Big Health, Happify, Omada Health Inc., Pear Therapeutics and Welldoc
Companies Mentioned
AKILI INTERACTIVE LABS INC.
Big Health
Click Therapeutics
HAPPIFY
OMADA HEALTH INC.
OREXO AB
Pear Therapeutics
PROPELLER HEALTH
Voluntis
WELLDOC
Report Scope:
The current report covers the booming technology of digital therapeutics. It also investigates the current shift in trends away from conventional methods of treatment toward the advanced means offered by digital therapeutics. This report is an update of an earlier report of the same title but focuses on more in-depth information. This report offers a comprehensive analysis of the global digital therapeutics market. Segmentation is based on application and sales channels. Based on application, the market is segmented as diabetes, psychiatric and addiction, neurological, cardiovascular diseases, and others. Based on sales channel the market is segmented as business-to-consumer (B2C) and business-to-business (B2B). The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). For market estimates, data has been provided for 2019, 2020, and 2021 as the base year, 2022, and a forecast for 2027.
The report provides a detailed overview and analysis of the present and future global market for digital therapeutics. Industry growth drivers, restraints, and opportunities are also discussed in detail. The report also provides a competitive landscape, elaborative company profiles, and the impact of COVID-19 on the market. The report focuses on the companies that are developing and encouraging digital therapeutics technology and doing research to develop the technology further.
Report Includes:
A brief general outlook of the global market for digital therapeutics scenario
Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Highlights of the current and upcoming market potential for digital therapeutics, and areas of focus to forecast this market into various segments and subsegments
Updated information on market opportunities and drivers, key shifts and trends, regulations and industry specific challenges, and other factors that will shape this market demand in the coming years (2022-2027)
Identification of the companies best positioned to meet the demand owing to their proprietary technologies, product launches, mergers and acquisitions, and other market strategic advantages
Review of the technology landscape for digital therapeutics marketplace with emphasis on recently approved products as well as products under development or in different stages of clinical trials
Profile descriptions of the market leading participants, including Big Health, Happify, Omada Health Inc., Pear Therapeutics and Welldoc
Companies Mentioned
AKILI INTERACTIVE LABS INC.
Big Health
Click Therapeutics
HAPPIFY
OMADA HEALTH INC.
OREXO AB
Pear Therapeutics
PROPELLER HEALTH
Voluntis
WELLDOC
Table of Contents
61 Pages
- Chapter 1 Market Outlook
- 1.1 Market Snapshot
- Chapter 2 Summary and Highlights
- Chapter 3 Market Overview
- 3.1 Overview
- 3.2 Evolution of Digital Therapeutics
- 3.3 Regulatory Framework
- 3.4 Reimbursement
- 3.5 Benefits of Digital Therapeutics
- 3.6 Digital Therapeutics Ecosystem
- Chapter 4 Market Dynamics
- 4.1 Factors Affecting the Digital Therapeutics Market
- 4.2 Market Drivers
- 4.2.1 Increasing Incidence of Chronic Diseases
- 4.2.2 Increasing Investments
- 4.2.3 Increasing Preventive Healthcare
- 4.2.4 Cost-Effective
- 4.2.5 Rising Use of mHealth Apps and Wearables
- 4.3 Market Restraints
- 4.3.1 Physician Adoption
- 4.3.2 Data Privacy and Security Concerns
- 4.3.3 Regulatory Approval
- 4.3.4 Reimbursement
- 4.4 Opportunities
- 4.4.1 Growing Technology Innovations
- 4.5 Impact of COVID-19
- Chapter 5 Digital Therapeutics Market by Application
- 5.1 Global Digital Therapeutics Market by Application
- 5.2 Diabetes
- 5.3 Psychiatric Conditions and Addictions
- 5.4 Cardiovascular Diseases
- 5.5 Neurological Diseases
- 5.6 Other Diseases
- Chapter 6 Digital Therapeutics Market by Sales Channel
- 6.1 Business-to-Business (B2B)
- 6.2 Business-to-Consumer (B2C)
- Chapter 7 Digital Therapeutics Market by Region
- 7.1 North America
- 7.2 Europe
- 7.3 Asia-Pacific
- 7.4 Rest of the World
- Chapter 8 Competitive Landscape and Analysis of Market Opportunities
- 8.1 Strategic Initiatives
- 8.2 Competitive Analysis
- Chapter 9 Company Profiles
- AKILI INTERACTIVE LABS INC.
- BIG HEALTH
- CLICK THERAPEUTICS
- HAPPIFY
- OMADA HEALTH INC.
- OREXO AB
- PEAR THERAPEUTICS
- PROPELLER HEALTH
- VOLUNTIS
- WELLDOC
- Chapter 10 Project Scope and Methodology
- 10.1 Study Goals and Objectives
- 10.2 Reasons for Doing This Study
- 10.3 Scope of Report
- 10.4 What's New in This Update?
- 10.5 Information Sources
- 10.6 Methodology
- 10.7 Geographic Breakdown
- 10.8 Analyst's Credentials
- 10.9 BCC Custom Research
- 10.10 Related BCC Research Reports
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
